Last updated: May 7, 2024
Sponsor: The University of Hong Kong
Overall Status: Active - Recruiting
Phase
N/A
Condition
Asperger's Disorder
Autism
Autism Spectrum Disorder (Asd)
Treatment
Electromagnetic therapy
Clinical Study ID
NCT06085287
UW 23-273
Ages 3-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- aged 3-12 years;
- have had a principal diagnosis of ASD according to the diagnostic criteria for ASD inthe DSM-5;
- The score of CARS is 30-37 (mild to moderate ASD) at entry; and
- his/her parents or legal guardian give a written informed consent that indicates thepermission to participate in the study.
Exclusion
Exclusion Criteria:
- Children suffer a significant comorbid congenital disease or brain injury, such asDown syndrome, mental retardation, and cerebral palsy;
- Children have been suffering uncontrolled epilepsy or seizure;
- Children have heart diseases;
- Children have participated in other investigational studies in previous 3 months;
- Children have pediatric massage or acupuncture in previous 2 months; or
- they have severe skin lesions or scar on the areas the treatment will be performed.
Study Design
Total Participants: 30
Treatment Group(s): 1
Primary Treatment: Electromagnetic therapy
Phase:
Study Start date:
March 01, 2024
Estimated Completion Date:
December 31, 2025
Connect with a study center
Clinical Services Centres, The School of Chinese Medicine, The University of Hong Kong
Hong Kong,
Hong KongActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.